Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Residual sinonasal ameloblastoma

Breadcrumb

  • Home
  • Residual Sinonasal Ameloblastoma
  • Residual sinonasal ameloblastoma

I Nyoman Endi Ananda Khrisna *, I Gde Ardika Nuaba and I Ketut Suanda

Department of Otorhinolaryngology, Medical Faculty of Udayana University, Denpasar, Indonesia.
 
Research Article
GSC Advanced Research and Reviews, 2023, 15(01), 098–102.
Article DOI: 10.30574/gscarr.2023.15.1.0120
DOI url: https://doi.org/10.30574/gscarr.2023.15.1.0120
Received on 03 March 2023; revised on 12 April 2023; accepted on 15 April 2023
 
Ameloblastoma is the most common odontogenic tumour of the mandible. This disease can occur in the maxilla, but it is very rare. This tumour originates from the epithelium involved in the process of tooth formation, but the trigger for neoplastic transformation in the epithelium still is not known with certainty. Ameloblastoma is defined as a locally aggressive benign tumour with a high probability of recurrence. These tumours have several variations in histopathological appearance, but the types most often seen are the follicular and plexiform types. In most cases, ameloblastoma is locally invasive, usually asymptomatic and slow growing.
It has been reported that a 45-year-old female patient with residual sinonasal ameloblastoma had a lateral rhinotomy performed using the Weber-Ferguson approach with good surgical results. Sinonasal ameloblastoma is a rare case with a high recurrence rate after surgery. Ameloblastoma can be diagnosed based on anamnesis, physical examination, and supporting examinations consisting of a CT scan and histopathology. Surgery is the standard treatment for ameloblastoma. A wide excision should be performed with 2 cm of normal bone removed from around the tumour margin to prevent the re-occurrence.
 
Residual Sinonasal Ameloblastoma; Wide excision; Lateral rhinotomy; Midfacial Degloving; Odontogenic
 
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2023-…

Preview Article PDF

I Nyoman Endi Ananda Khrisna, I Gde Ardika Nuaba and I Ketut Suanda. Residual sinonasal ameloblastoma. GSC Advanced Research and Reviews, 2023, 15(1), 098-102. Article DOI: https://doi.org/10.30574/gscarr.2023.15.1.0120

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution